loading...| Preferred Name |
Anaphylactic Shock |
|
| Synonyms |
|
|
| Definitions |
Progression of anaphylaxis into systemic shock, which is characterized by significant reduction in tissue perfusion which leads to hypoxia and hypotension, and can lead to death if untreated. |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C50460 |
|
| ALT_DEFINITION |
A severe and sometimes life-threatening immune system reaction to an antigen that a person has been previously exposed to. The reaction may include itchy skin, edema, collapsed blood vessels, fainting, difficulty in breathing, and death. Progression of anaphylaxis into systemic shock, which is characterized by significant reduction in tissue perfusion which leads to hypoxia and hypotension, and can lead to death if untreated. |
|
| code |
C50460 |
|
| Contributing_Source |
FDA |
|
| database_cross_reference |
IMDRF:E040201 |
|
| definition |
Progression of anaphylaxis into systemic shock, which is characterized by significant reduction in tissue perfusion which leads to hypoxia and hypotension, and can lead to death if untreated. |
|
| FDA_Table |
Patient Code (Appendix B) |
|
| in_subset | ||
| label |
Anaphylactic Shock |
|
| Legacy Concept Name |
Anaphylactic_Shock |
|
| Preferred_Name |
Anaphylactic Shock |
|
| prefixIRI |
NCIT:C50460 |
|
| prefLabel |
Anaphylactic Shock |
|
| Semantic_Type |
Finding |
|
| UMLS_CUI |
C0857035 |
|
| subClassOf |